9,342 Shares in Astera Labs, Inc. $ALAB Bought by Paragon Advisors LLC

Paragon Advisors LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,342 shares of the company’s stock, valued at approximately $1,829,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. TD Waterhouse Canada Inc. boosted its stake in Astera Labs by 7.0% in the third quarter. TD Waterhouse Canada Inc. now owns 16,434 shares of the company’s stock valued at $2,946,000 after acquiring an additional 1,073 shares during the period. one8zero8 LLC bought a new position in Astera Labs in the 3rd quarter worth about $323,000. Mirae Asset Global Investments Co. Ltd. increased its position in Astera Labs by 16,543.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 196,560 shares of the company’s stock valued at $38,486,000 after acquiring an additional 195,379 shares during the period. Federated Hermes Inc. raised its stake in Astera Labs by 91.9% during the 3rd quarter. Federated Hermes Inc. now owns 278,305 shares of the company’s stock valued at $54,492,000 after acquiring an additional 133,305 shares in the last quarter. Finally, Truist Financial Corp grew its stake in shares of Astera Labs by 270.0% in the third quarter. Truist Financial Corp now owns 35,062 shares of the company’s stock worth $6,865,000 after purchasing an additional 25,585 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $167.90 on Thursday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a fifty day moving average price of $163.38 and a 200 day moving average price of $170.80. The stock has a market cap of $28.36 billion, a P/E ratio of 151.26, a PEG ratio of 2.33 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the prior year, the company posted $0.23 EPS. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ALAB shares. Bank of America initiated coverage on Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price for the company. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Northland Securities upped their target price on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Royal Bank Of Canada assumed coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective for the company. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. This represents a 4.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the company’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the sale, the director owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 576,936 shares of company stock valued at $87,409,540 over the last quarter. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.